2022 Revenues ($USD) : $6,402,977,058
2022 Revenues (foreign currencies) : JP¥703,303,000,000
2022 R&D spend : n/a
2022 Number of Employees : 28,000
Fiscal Year End : 3/31/2022
Company CEO : Shinjiro Sato, president and CEO

Terumo is one of the few medical device companies with roots stretching back one century. Founded as a thermometer manufacturer, Terumo has a diversified range of products spanning interventional cardiology, blood transfusion and cell therapy. In addition to its presence in Asia, the Tokyo-based company has subsidiaries in the EMEA region, South America and North America. Since the mid-1990s, the company has developed devices for transradial intervention, a technique involving the insertion of a catheter in the wrist to grant blood vessel access. It also makes devices for diabetes care and peritoneal dialysis treatments. In total, the company offers 50,000 products and services. In 2022, the company renamed its General Hospital Co. to Medical Care Solutions Co, reflecting the growth of in-home care and a business expansion into extensive diabetes treatment solutions. –BB